Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

NCT: NCT05691972 · COMPLETED

NCT IDNCT05691972

StatusCOMPLETED

Start Date2023-03-14

Completion2024-12-11

SponsorGalderma R&D (INDUSTRY)

First posted2023-01-20

Last updated2026-05-22

Brief Summary

This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑